These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34144507)

  • 1. An autoregressive cross-lagged model unraveling co-occurring stimulant use and HIV: Results from a randomized controlled trial.
    Lee JY; Lee JE; Moskowitz JT; Feaster DJ; Neilands TB; Dilworth SE; Rodriguez A; Carrico AW
    Drug Alcohol Depend; 2021 Aug; 225():108752. PubMed ID: 34144507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
    Carrico AW; Neilands TB; Dilworth SE; Evans JL; Gόmez W; Jain JP; Gandhi M; Shoptaw S; Horvath KJ; Coffin L; Discepola MV; Andrews R; Woods WJ; Feaster DJ; Moskowitz JT
    J Int AIDS Soc; 2019 Dec; 22(12):e25436. PubMed ID: 31860172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of a positive affect intervention for methamphetamine users.
    Carrico AW; Gόmez W; Jain J; Shoptaw S; Discepola MV; Olem D; Lagana-Jackson J; Andrews R; Neilands TB; Dilworth SE; Evans JL; Woods WJ; Moskowitz JT
    Drug Alcohol Depend; 2018 Nov; 192():8-15. PubMed ID: 30195243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive affect intervention alters leukocyte DNA methylation in sexual minority men with HIV who use methamphetamine.
    Carrico AW; Cherenack EM; Flentje A; Moskowitz JT; Asam K; Ghanooni D; Chavez JV; Neilands TB; Dilworth SE; Rubin LH; Gouse H; Fuchs D; Paul RH; Aouizerat BE
    Brain Behav Immun; 2024 Aug; 120():151-158. PubMed ID: 38777283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community-engaged randomized controlled trial of an integrative intervention with HIV-positive, methamphetamine-using men who have sex with men.
    Carrico AW; Jain J; Discepola MV; Olem D; Andrews R; Woods WJ; Neilands TB; Shoptaw S; Gómez W; Dilworth SE; Moskowitz JT
    BMC Public Health; 2016 Jul; 16():673. PubMed ID: 27476110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant use interventions may strengthen 'Getting to Zero' HIV elimination initiatives in Illinois: Insights from a modeling study.
    Lee F; Sheeler D; Hotton A; Vecchio ND; Flores R; Fujimoto K; Harawa N; Schneider JA; Khanna AS
    Int J Drug Policy; 2022 May; 103():103628. PubMed ID: 35218990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersecting minority statuses and tryptophan degradation among stimulant-using, sexual minority men living with HIV.
    Vincent W; Carrico AW; Dilworth SE; Fuchs D; Neilands TB; Moskowitz JT; Flentje A
    J Consult Clin Psychol; 2021 Mar; 89(3):156-165. PubMed ID: 33829804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "The familiar taste of poison": a qualitative study of multi-level motivations for stimulant use in sexual minority men living in South Florida.
    Davis-Ewart L; Lee JY; Viamonte M; Colon-Burgos J; Harkness A; Kanamori M; Duncan DT; Doblecki-Lewis S; Carrico AW; Grov C
    Harm Reduct J; 2023 Apr; 20(1):58. PubMed ID: 37101251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    Chahine A; Koru-Sengul T; Feaster DJ; Dilworth SE; Antoni MH; Klatt N; Roach ME; Pallikkuth S; Sharkey M; Salinas J; Stevenson M; Pahwa S; Fuchs D; Carrico AW
    J Acquir Immune Defic Syndr; 2021 Mar; 86(3):353-360. PubMed ID: 33165125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine.
    Lee JY; Glynn TR; Moskowitz JT; Fuchs D; Neilands TB; Dilworth SE; Feaster DJ; Rodriguez A; Carrico AW
    J Neurovirol; 2021 Feb; 27(1):178-182. PubMed ID: 33460015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of prescription stimulant misuse with subsequent methamphetamine use among a U.S. cohort of HIV-vulnerable sexual and gender minorities who have sex with men.
    Westmoreland DA; Goldshear JL; Carrico AW; Grov C
    Drug Alcohol Depend; 2021 Sep; 226():108841. PubMed ID: 34271513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot trial of an expressive writing intervention with HIV-positive methamphetamine-using men who have sex with men.
    Carrico AW; Nation A; Gómez W; Sundberg J; Dilworth SE; Johnson MO; Moskowitz JT; Rose CD
    Psychol Addict Behav; 2015 Jun; 29(2):277-82. PubMed ID: 25437153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding Sunshine on a Cloudy Day: A Positive Affect Intervention for Co-Occurring Methamphetamine Use and HIV.
    Olem D; Earle M; Gómez W; Coffin L; Cotten P; Jain JP; Moskowitz JT; Carrico AW
    Cogn Behav Pract; 2022 May; 29(2):267-279. PubMed ID: 35812005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant use and HIV disease management among men in same-sex relationships.
    Carrico AW; Woolf-King SE; Neilands TB; Dilworth SE; Johnson MO
    Drug Alcohol Depend; 2014 Jun; 139():174-7. PubMed ID: 24726318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal Methamphetamine Use and Initiation among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV in a Treatment as Prevention Environment.
    Colyer SP; Moore DM; Cui Z; Zhu J; Armstrong HL; Taylor M; Edward J; Howard T; Dickie C; Olarewaju G; Montaner JSG; Hogg RS; Roth EA; Lachowsky NJ
    Subst Use Misuse; 2020; 55(14):2428-2437. PubMed ID: 33059493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-related drivers of sexual compulsivity and sexuality in sexual minority men who use methamphetamine.
    Kondur HR; Lee TK; McIntosh R; Gouse H; Paul R; Grov C; Fuchs D; Gómez W; Dilworth SE; Neilands TB; Carrico AW
    J Neurovirol; 2022 Jun; 28(3):446-455. PubMed ID: 35821194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of text messages to reduce methamphetamine use and HIV sexual risk behaviors among men who have sex with men.
    Reback CJ; Fletcher JB; Leibowitz AA
    J Subst Abuse Treat; 2019 May; 100():59-63. PubMed ID: 30898329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant use, HIV, and immune dysregulation among sexual minority men.
    Cherenack EM; Chavez JV; Martinez C; Hirshfield S; Balise R; Horvath KJ; Viamonte M; Jimenez DE; Paul R; Dilworth SE; DeVries B; Pallikkuth S; Stevenson M; Alvarado TC; Pahwa S; Carrico AW
    Drug Alcohol Depend; 2023 Oct; 251():110942. PubMed ID: 37651812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
    Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.